Position in RCUS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,529,169
-$404,111 QoQ
Shares Held
82,036
-39.6% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#81
of 230 holders
Holding Since
Sep 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Jump Financial, LLC holds $441,487,523 across 168 Biotechnology names. RCUS ranks #52 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
306,330 | $24,288,904 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
579,882 | $22,621,196 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
260,730 | $15,737,662 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
277,952 | $15,159,500 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
245,390 | $14,041,214 | |
| 6 | SRPT |
Sarepta Therapeutics, Inc.
|
679,445 | $12,209,626 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,242 | $10,127,536 | |
| 8 | RARE |
Ultragenyx Pharmaceutical Inc.
|
286,952 | $9,581,327 |
All Filings in RCUS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,529,169 | 82,036 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,933,280 | 135,800 | Shares | Defined | 2026-05-14 | |
| 2024-12-31 | $256,763 | 17,244 | Shares | Defined | 2025-02-13 | |
| 2024-03-31 | $607,746 | 32,190 | Shares | Sole | 2024-05-13 | |
| 2023-06-30 | $1,298,235 | 63,921 | Shares | Sole | 2024-10-21 | |
| 2021-12-31 | $395,918 | 9,783 | Shares | Sole | 2022-02-10 | |
| 2020-12-31 | $450,639 | 17,359 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $345,113 | 20,135 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||